Variant report
Variant | nsv600451 |
---|---|
Chromosome Location | chr5:178112451-178120334 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:178119500..178121494-chr5:178122164..178124985,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183806578 | chr5:178112471-178112472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs372125716 | chr5:178112523-178112524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs547594298 | chr5:178112532-178112533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561494913 | chr5:178112575-178112576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541874606 | chr5:178112601-178112602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs565931378 | chr5:178112679-178112680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs539174877 | chr5:178112682-178112683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557817368 | chr5:178112715-178112716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576020552 | chr5:178112729-178112730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537070183 | chr5:178112739-178112740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562366082 | chr5:178112775-178112776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573886943 | chr5:178112794-178112795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs187901435 | chr5:178112809-178112810 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs148453759 | chr5:178112880-178112881 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs142595945 | chr5:178112936-178112937 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs535146921 | chr5:178112978-178112979 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs190256249 | chr5:178112999-178113000 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs6864012 | chr5:178113016-178113017 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs182549884 | chr5:178113044-178113045 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs150988944 | chr5:178113165-178113166 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547968243 | chr5:178113259-178113260 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs374620732 | chr5:178113290-178113291 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs559004106 | chr5:178113352-178113353 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547663087 | chr5:178113381-178113382 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565966989 | chr5:178113393-178113394 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs374305519 | chr5:178113404-178113405 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533363247 | chr5:178113432-178113433 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374248955 | chr5:178113438-178113439 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs57367224 | chr5:178113458-178113459 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs113378656 | chr5:178113512-178113513 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs111309141 | chr5:178113523-178113524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs550957727 | chr5:178113543-178113544 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs543969415 | chr5:178113644-178113645 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs111782072 | chr5:178113645-178113646 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555379234 | chr5:178113667-178113668 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs373096321 | chr5:178113679-178113680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567269912 | chr5:178113743-178113744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs555145537 | chr5:178113836-178113837 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565800536 | chr5:178113838-178113839 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191366055 | chr5:178113844-178113845 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs185421113 | chr5:178113845-178113846 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534313319 | chr5:178113850-178113851 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs111517265 | chr5:178113877-178113878 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
44 | rs370824139 | chr5:178113889-178113890 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550516715 | chr5:178113895-178113896 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs374797111 | chr5:178113923-178113924 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs557780314 | chr5:178113935-178113936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs189188777 | chr5:178113936-178113937 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs578238174 | chr5:178113940-178113941 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs373086318 | chr5:178113945-178113946 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
epilepsy | 18472482 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Sotos syndrome | 21572526 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Sotos syndrome | 17561922 | CNVD |
Sotos syndrome | 16773131 | CNVD |
Mental retardation | 16773131 | CNVD |
Sotos syndrome | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Lung cancer | 17297452 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sotos syndrome | 22283845 | CNVD |
Breast cancer | 16272173 | CNVD |
Sotos syndrome | 20503325 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 19181860 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ehlers-danlos syndrome | 17576883 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19246517 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Breast cancer | 21990379 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:178110200-178113200 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr5:178111600-178113400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
3 | chr5:178112000-178115400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
4 | chr5:178112200-178112800 | Enhancers | Placenta | Placenta |
5 | chr5:178112800-178113400 | Flanking Active TSS | Placenta | Placenta |
6 | chr5:178113200-178115200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
7 | chr5:178113400-178113800 | Enhancers | Placenta | Placenta |
8 | chr5:178113400-178115000 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
9 | chr5:178115000-178115400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
10 | chr5:178115200-178116400 | Enhancers | Primary monocytes fromperipheralblood | blood |
11 | chr5:178115400-178116000 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
12 | chr5:178115400-178116200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
13 | chr5:178115400-178116400 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
14 | chr5:178115400-178117200 | Enhancers | HMEC | breast |
15 | chr5:178115400-178118000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
16 | chr5:178116000-178117200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
17 | chr5:178116400-178117000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
18 | chr5:178118000-178122000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |